A Study of Enasidenib in People With T-Cell Lymphoma
Recruiting
The researchers are doing this study to find out whether enasidenib is a safe treatment for people with angioimmunoblastic T-cell lymphoma (AITL) that has an IDH2 mutation. The researchers will look at the safety of enasidenib when it is given alone or in combination with the drug rituximab.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts +7 locations
Conditions: T-cell Lymphoma
Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units
Recruiting
The goal of this study is to explore if Virtual Reality helps patients in the cardiothoracic ICU move more and feel better. Participants will be asked to answer a survey about anxiety, depression, and loneliness. The study team will teach participants how to use the VR device and how to play the game. Participants will play the game at least once per day, but can play as much as they want. Study activities include nurse facilitated patient use of VR applications that involve upper body movement... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: Duke University Hospital, Durham, North Carolina
Conditions: Mobility, ICU, Heart Surgery, Nursing
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
Recruiting
The purpose of this study is to determine: 1. The highest dose of the trial intervention that targets neuroendocrine tumors and is tolerated by patients. 2. The highest frequency of dosing of the trial intervention that targets neuroendocrine tumors and is tolerated by patients. 3. The highest dose and frequency of dosing of the trial intervention that targets neuroendocrine tumors with at least the same degree of effectiveness and tolerability as currently available (standard of care) treatmen... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: University of Miami, Miami, Florida
Conditions: Neuroendocrine Carcinoma, Neuroendocrine Tumors
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Recruiting
Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer overall and live longer without the cancer growing or spreading than people who receive chemotherapy,
Gender:
MALE
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids, Michigan +23 locations
Conditions: Prostate Cancer, Prostatic Neoplasms
Project PAIR: Parent-implemented Articulation Intervention With Recast
Recruiting
Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Recast supplemented with traditional clinician-led articulation therapy on speech production in elementary-aged deaf and hard of hearing children. To address these objectives, the following research questions will be investigated: 1. Does drill-based articulation therapy, administered by a speech-language pathologist, improve speech sound p... Read More
Gender:
ALL
Ages:
Between 4 years and 10 years
Trial Updated:
06/26/2025
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Hearing Impaired Children
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
Recruiting
Food insecurity affects up to 30% of pregnancies and leads to worse health in pregnant people and their children, including an increased risk of gestational diabetes, pre-term birth, and future cardiometabolic chronic conditions (e.g., type 2 diabetes and obesity). Interventions are being utilized to address food insecurity in clinical care settings, but patients differ in the support needed to reduce food insecurity and health systems have limited resources to invest in these interventions. Rat... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Conditions: Food Insecurity, Pregnancy
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
Recruiting
The purpose of this research study is to look at genes and determine how they interact with each other to find changes that could explain why some people's immune systems may respond to blood transfusions. This response is called an alloimmune response. We strongly believe that when someone has an alloimmune response, it is caused by changes in their genes. We plan to compare changes in the genes of individuals that develop red blood cell alloimmunization after blood transfusions with those that... Read More
Gender:
ALL
Ages:
Between 2 years and 99 years
Trial Updated:
06/26/2025
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Sickle Cell Disease
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Recruiting
The goal of this clinical trial is to learn about how certain medications used to treat insomnia (e.g., Lemborexant) impact sleep, mood, and behavior in men and women with Opioid Use Disorder who are taking prescribed buprenorphine. The main questions it aims to answer are: 1. What is the effect of the study drug (lemborexant) on sleep outcomes? 2. What is the effect of the study drug (lemborexant) on impulsive behavior (as measured by computer test performance)? 3. What is the effect of the st... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: VCU Institute for Drug and Alcohol Studies, Richmond, Virginia
Conditions: Opioid Use Disorder, Opioid Use, Insomnia, Orexin Antagonist
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
Recruiting
To learn if reconstruction of the lymphatic system at the time of axillary lymphadenectomy can reduce the risk of developing lymphedema.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Lymphedema
The Role of hCG in Thawed Embryo Transfer
Recruiting
This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: Fertility Center of Las Vegas, Las Vegas, Nevada
Conditions: Infertility (IVF Patients)
Mindfulness to Enhance Cognitive Health in Latinx Older Adults
Recruiting
The primary objective of the proposed research is to investigate the promise and underlying mechanisms of mindfulness training as a preventative lifestyle intervention to enhance cognitive health in Latinx older adults, thereby mitigating risk of Alzheimer's Disease (AD) in a population that may be particularly vulnerable.
Gender:
ALL
Ages:
65 years and above
Trial Updated:
06/26/2025
Locations: Washington University, Saint Louis, Missouri
Conditions: Mindfulness, Alzheimer's Disease Related Dementia
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
Recruiting
The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this intervention could be a companion intervention for Cancer providers in combination with the already in testing DISCO app (Discussions of Cost App) for patients. Participants will: * complete a baseline survey * attend two one on one meetings, one as part of the development and the second as part of the pi... Read More
Gender:
ALL
Ages:
All
Trial Updated:
06/26/2025
Locations: Karmanos Cancer Institute, Detroit, Michigan
Conditions: Healthy, Financial Toxicity